awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33436890-68945FD3-B804-4A49-955E-595F37803881
Q33436890-68945FD3-B804-4A49-955E-595F37803881
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436890-68945FD3-B804-4A49-955E-595F37803881
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
P2860
Q33436890-68945FD3-B804-4A49-955E-595F37803881
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436890-68945FD3-B804-4A49-955E-595F37803881
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b356c81f7164ed8af0e382b489dfd7078db5d0e
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.